Published in J Neurol Neurosurg Psychiatry on June 01, 2002
Vascular risk factors, cognitive decline, and dementia. Vasc Health Risk Manag (2008) 2.13
Biomarkers of Alzheimer disease in plasma. NeuroRx (2004) 2.02
Oxidative modification to LDL receptor-related protein 1 in hippocampus from subjects with Alzheimer disease: implications for Aβ accumulation in AD brain. Free Radic Biol Med (2010) 0.95
Serum lipids are related to Alzheimer's pathology in nursing home residents. Dement Geriatr Cogn Disord (2009) 0.87
Cholesterol and LDL relate to neuritic plaques and to APOE4 presence but not to neurofibrillary tangles. Curr Alzheimer Res (2011) 0.86
Development of classification models for early identification of persons at risk for persistent cognitive decline. J Neurol (2008) 0.82
Elevation of peripheral BDNF promoter methylation links to the risk of Alzheimer's disease. PLoS One (2014) 0.81
Serum cholesterol and variant in cholesterol-related gene CETP predict white matter microstructure. Neurobiol Aging (2014) 0.79
Is lipoprotein (a) protective of dementia? Eur J Epidemiol (2016) 0.77
Genomic Characteristics of Genetic Creutzfeldt-Jakob Disease Patients with V180I Mutation and Associations with Other Neurodegenerative Disorders. PLoS One (2016) 0.75
Relationship between plasma lipids and mild cognitive impairment in the elderly Chinese: a case-control study. Lipids Health Dis (2016) 0.75
Plasma anti-α-galactoside antibody mediates lipoprotein(a) binding to macrophages. Glycoconj J (2016) 0.75
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology (1984) 119.59
A rating scale for depression. J Neurol Neurosurg Psychiatry (1960) 90.89
A new clinical scale for the staging of dementia. Br J Psychiatry (1982) 21.77
Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology (1993) 14.54
The impact of confounder selection criteria on effect estimation. Am J Epidemiol (1989) 13.34
Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA (1997) 10.75
Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet (1997) 5.04
Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J Clin Invest (1992) 3.05
The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Brain Res Rev (1995) 3.05
Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease. Neuroepidemiology (1998) 2.83
Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann Neurol (1997) 2.67
Frequency and distribution of Alzheimer's disease in Europe: a collaborative study of 1980-1990 prevalence findings. The EURODEM-Prevalence Research Group. Ann Neurol (1991) 1.89
Lipoprotein(a) and lipoprotein profile in healthy centenarians: a reappraisal of vascular risk factors. FASEB J (1998) 1.77
Elevated low-density lipoprotein in Alzheimer's disease correlates with brain abeta 1-42 levels. Biochem Biophys Res Commun (1998) 1.72
Partial amino acid sequence of apolipoprotein(a) shows that it is homologous to plasminogen. Proc Natl Acad Sci U S A (1987) 1.61
Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease: a case-control study. Neurology (1995) 1.55
APOE genotype, plasma lipids, lipoproteins, and AD in community elderly. Neurology (1999) 1.44
Effects of age, sex, and menopausal status on plasma lipoprotein(a) levels. The Framingham Offspring Study. Circulation (1993) 1.24
Diagnostic evaluation of degenerative and vascular dementia. Stroke (1984) 1.16
Lipoprotein(a) as a strong indicator for cerebrovascular disease. Stroke (1986) 1.14
In search of a biological pattern for human longevity: impact of apo A-IV genetic polymorphisms on lipoproteins and the hyper-Lp(a) in centenarians. Atherosclerosis (1998) 0.88
Increased amyloid protein precursor and apolipoprotein E immunoreactivity in the selectively vulnerable hippocampus following transient forebrain ischemia in gerbils. Exp Neurol (1995) 0.87
Lipoprotein(a) in stored plasma samples and the ravages of time. Why epidemiological studies might fail. Arterioscler Thromb Vasc Biol (1996) 0.85
Interactions between apolipoprotein E and apolipoprotein(a) in patients with late-onset Alzheimer disease. Ann Intern Med (2000) 0.84
Apolipoprotein E in Southern Italy: protective effect of epsilon 2 allele in early- and late-onset sporadic Alzheimer's disease. Neurosci Lett (2000) 0.84
Apolipoprotein E polymorphism affects plasma levels of lipoprotein(a). Atherosclerosis (1991) 0.84
Decreased frequency of apolipoprotein E epsilon4 allele from Northern to Southern Europe in Alzheimer's disease patients and centenarians. Neurosci Lett (1999) 0.80
Metabolic and anthropometric determinants of serum Lp(a) concentrations and Apo(a) polymorphism in a healthy Arab population. Int J Obes Relat Metab Disord (1999) 0.78
Lipoprotein(a) phenotypes in patients with vascular dementia. Dement Geriatr Cogn Disord (2000) 0.77
Aphasia and Wernicke's arc. J Neurol Neurosurg Psychiatry (2001) 0.77
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
Vascular risk factors, incidence of MCI, and rates of progression to dementia. Neurology (2004) 2.81
APOE and Alzheimer disease: a major gene with semi-dominant inheritance. Mol Psychiatry (2011) 2.31
A-IMilano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family. J Clin Invest (1980) 2.27
Stroke in the very old : clinical presentation and determinants of 3-month functional outcome: A European perspective. European BIOMED Study of Stroke Care Group. Stroke (1999) 1.56
Diabetes mellitus, hypertension and medial temporal lobe atrophy: the LADIS study. Diabet Med (2007) 1.25
Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease. Mol Psychiatry (2012) 1.20
Predictors of high level of burden and distress in caregivers of demented patients: results of an Italian multicenter study. Int J Geriatr Psychiatry (2005) 1.15
The role of diet in cognitive decline. J Neural Transm (Vienna) (2003) 1.13
The lipoprotein abnormality in Tangier disease: quantitation of A apoproteins. J Clin Invest (1977) 1.12
Alcohol consumption, mild cognitive impairment, and progression to dementia. Neurology (2007) 1.12
Mediterranean diet and cognitive decline. Public Health Nutr (2004) 1.10
Short-term effects of high-intensity laser therapy versus ultrasound therapy in the treatment of low back pain: a randomized controlled trial. Eur J Phys Rehabil Med (2011) 1.07
Shifts in angiotensin I converting enzyme insertion allele frequency across Europe: implications for Alzheimer's disease risk. J Neurol Neurosurg Psychiatry (2003) 1.07
High monounsaturated fatty acids intake protects against age-related cognitive decline. Neurology (1999) 1.05
Clinical significance of corpus callosum atrophy in a mixed elderly population. Neurobiol Aging (2006) 1.04
White matter changes contribute to corpus callosum atrophy in the elderly: the LADIS study. AJNR Am J Neuroradiol (2008) 0.97
Towards disease-modifying treatment of Alzheimer's disease: drugs targeting beta-amyloid. Curr Alzheimer Res (2010) 0.97
Medial temporal lobe atrophy and white matter hyperintensities are associated with mild cognitive deficits in non-disabled elderly people: the LADIS study. J Neurol Neurosurg Psychiatry (2005) 0.96
Apoprotein A metabolism in Tangier disease. Atherosclerosis (1978) 0.94
Plasma lipids, lipoproteins and apoproteins in a case of apo C-II deficiency. Clin Chim Acta (1983) 0.88
In search of a biological pattern for human longevity: impact of apo A-IV genetic polymorphisms on lipoproteins and the hyper-Lp(a) in centenarians. Atherosclerosis (1998) 0.88
Relationship of the phenotypic expression of the A-IMilano apoprotein with plasma lipid and lipoprotein patterns. Atherosclerosis (1985) 0.87
Nimodipine in the treatment of old age dementias. Prog Neuropsychopharmacol Biol Psychiatry (1990) 0.87
The missing ApoE allele. Ann Hum Genet (2007) 0.86
Mediterranean diet in predementia and dementia syndromes. Curr Alzheimer Res (2011) 0.86
New case of apoprotein C-II deficiency. Lancet (1980) 0.86
Free IL-18 and IL-33 cytokines in chronic spontaneous urticaria. Cytokine (2013) 0.84
Dietary fatty acids, age-related cognitive decline, and mild cognitive impairment. J Nutr Health Aging (2008) 0.84
[DNA-content in the nuclei of auricular appendices]. Virchows Arch B Cell Pathol (1970) 0.84
Apolipoprotein E in Southern Italy: protective effect of epsilon 2 allele in early- and late-onset sporadic Alzheimer's disease. Neurosci Lett (2000) 0.84
Identification of the mutation responsible for a case of plasmatic apolipoprotein CII deficiency (Apo CII-Bari). Biochem Biophys Res Commun (1990) 0.84
[Common presence on strawberries of ascospores of Byssochlamys nivea capable of producing patulin]. Mycopathologia (1975) 0.83
Sex chromosome loss, micronuclei, sister chromatid exchange and aging: a study including 16 centenarians. Mutat Res (2001) 0.82
Evaluation of five commercial Sabouraud gentamicin-chloramphenicol agar media. Eur J Clin Microbiol Infect Dis (2001) 0.82
Abulia and cognitive impairment in two patients with capsular genu infarct. Acta Neurol Scand (2001) 0.82
Vascular risk factors, alcohol intake, and cognitive decline. J Nutr Health Aging (2008) 0.82
Vascular risk and genetics of sporadic late-onset Alzheimer's disease. J Neural Transm (Vienna) (2003) 0.81
Safety and efficacy of incobotulinum toxin type A (NT 201-Xeomin) for the treatment of post-stroke lower limb spasticity: a prospective open-label study. Eur J Phys Rehabil Med (2013) 0.81
Idebenone in senile dementia of Alzheimer type: a multicentre study. Arch Gerontol Geriatr (2004) 0.81
Increased bile acid excretion and reduction of serum cholesterol after crenotherapy with salt-rich mineral water. Aging (Milano) (1999) 0.81
Clinically relevant cognitive impairment after cardiac surgery: a 6-month follow-up study. J Neurol Sci (2001) 0.80
Thrombophilic risk factors and unusual clinical features in three Italian CADASIL patients. Eur J Neurol (2004) 0.80
Decreased frequency of apolipoprotein E epsilon4 allele from Northern to Southern Europe in Alzheimer's disease patients and centenarians. Neurosci Lett (1999) 0.80
A G----C change at the donor splice site of intron 1 causes lipoprotein lipase deficiency in a southern-Italian family. Biochem Biophys Res Commun (1992) 0.78
Changes in severity of depressive symptoms and mortality: the Italian Longitudinal Study on Aging. Psychol Med (2012) 0.78
Mild cognitive impairment: risk of Alzheimer disease and rate of cognitive decline. Neurology (2007) 0.78
Influence of vascular risk factors and neuropsychological profile on functional performances in CADASIL: results from the MIcrovascular LEukoencephalopathy Study (MILES). Eur J Neurol (2013) 0.78
F175S change and a novel polymorphism in presenilin-1 gene in late-onset familial Alzheimer's disease. Eur Neurol (2002) 0.77
Comparison of nuclear matrix protein 22 and bladder tumor antigen in urine of patients with bladder cancer. Anticancer Res (1999) 0.77
Preserved antilipolytic insulin action is associated with a less atherogenic plasma lipid profile in healthy centenarians. J Am Geriatr Soc (1997) 0.77